Robert Dribbon is director of business development at the GTMRx Institute. Previously, he served as executive member liaison to the PCPCC Board of Directors through his role at Merck. While at Merck, Rob served as director of strategy and business development, U.S. Customer Centricity, focused on Merck’s top customers and stakeholders in areas of mutual interest. His most recent previous role was in U.S. strategy and planning, where he was responsible for assessing health care market trends to inform Merck’s U.S. market and to determine the impact of these trends on Merck’s customers and business. He played a significant role in representing Merck in efforts to shape the health care market and improve the delivery and quality of health care in the United States.
His leadership and collaboration with stakeholders on the patient-centered medical home model is one example of his efforts. During the course of his career at Merck, Rob has held a wide range of positions of increasing responsibility in marketing, sales, managed care and strategy. His experience extends to many therapeutic areas as well as multiple health care segments, including primary care, subspecialty, health plan, federal, state, hospital, long-term care, pharmacy, employer and consumer. He gained a breadth of experience working across multiple divisions of Merck. In 2012, he was one of the first five employees across Merck selected as a fellow in the Richard T. Clark Fellowship for World Health, a global program designed to support the efforts of humanitarian organizations to answer the health needs of the underserved.
Rob is a graduate of Rutgers University where he was a Henry Rutgers Scholar.